行为激活与通常对初级保健中抑郁老年人的治疗:实用集群随机对照试验
Noortje P Janssen1,2,3, Peter Lucassen2, Marcus J H Huibers4
1Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
Psychotherapy and psychosomatics
|June 29, 2023
概括
与通常治疗 (TAU) 相比,行为激活 (BA) 在治疗后立即和3个月后显著降低了老年人的抑郁症状. 然而,这些好处并没有长期存在.
科学领域:
- 老年学是一门学科.
- 精神病学是一个精神病学.
- 主要护理医学 医疗保健
背景情况:
- 对老年人的抑郁症有效的非药物治疗方法有限.
- 精神卫生护士 (MHN) 可以在初级保健机构提供干预.
研究的目的:
- 评估MHN在初级保健中为患有抑郁症的老年人提供行为激活 (BA) 的有效性.
- 为了将BA与通常治疗 (TAU) 进行比较.
主要方法:
- 一个多中心集群随机对照试验,涉及161名患有抑郁症状的老年人 (≥65岁).
- 参与者被随机分配到一个为期8周的MHN主导的BA计划或TAU.
- 使用QIDS-SR16在多个随访点测量抑郁症的严重程度,长达12个月.
主要成果:
- 与TAU相比,BA显著减少了治疗后 (p < 0.001) 和3个月随访后 (p = 0.02) 的抑郁症状.
- 效应大小在治疗后为0.90,在3个月后为0.50.
- 症状减轻的显著差异在6至12个月的随访中没有维持.
结论:
- 行为激活 (BA) 是一种有效的非药物干预措施,用于减少初级保健机构中老年人抑郁症症状.
- 在治疗后3个月内观察到BA的积极影响.
- 与TAU相比,BA的长期有效性 (超过3个月) 需要进一步调查.
更多相关视频
08:25Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
433
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.8K
相关概念视频
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Electroconvulsive Therapy
75
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
75
Operant Conditioning Intervention
88
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
88
Treatment Strategies for Psychological Disorders
175
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
175
Antidepressant Drugs: MAOIs and Other Agents
277
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
277
Alzheimer's Disease: Treatment
220
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
220
